Manufacturing Execution System (MES) Providers in Healthcare Market Size, Share & Trends Analysis Report By Deployment(Cloud Solutions, Corporate Datacenter Solutions, Hybrid Solutions, On-Premise Solutions), By End-Users, By Region, And By Segment Forecasts, 2025-2034

Report Id: 1359 Pages: 190 Last Updated: 16 April 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Manufacturing Execution System (MES) Providers in Healthcare Market Size is valued at USD 4.0 Billion in 2024 and is predicted to reach USD 17.4 Billion by the year 2034 at a 15.9% CAGR during the forecast period for 2025-2034.

Manufacturing execution systems (MES) are computerized systems that track and document the transformation of raw materials to finished commodities in manufacturing. MES delivers information that assists manufacturing decision-makers in understanding the plant floor conditions to increase production output. Biotech, pharmaceutical, and medical device companies must have accurate information from their supply chain, verify that the equipment on the factory floor is operational, and adhere to tight quality control standards and laws. They assist pharmaceutical businesses in developing faultless production processes that decrease risks, time, costs, and effort while increasing process efficiency and product quality.

Several healthcare stakeholders have taken active steps to integrate a manufacturing execution system into their production lines to connect, monitor, and control the complicated manufacturing process. It has also been observed that enterprises are increasingly embracing cloud-based manufacturing execution systems to solve the issues associated with increased process complexity and worldwide business expansion.

Manufacturing Execution System (MES) Providers in Healthcare Market

The need for mass production and a connected supply chain to serve a growing population, rapid advancements in infrastructure and manufacturing equipment, and improved innovations in medical care will all contribute to an increase in the demand for MES and other management systems to meet the demands of production across the world. This increase in demand for MES and other management systems is expected to take place in the next few years. In addition, cloud computing will be one of the growth drivers of MES usage, along with digital transformation, IIoT, and additional integrated ways to leverage connected data, including advanced data and analytics platforms, as certain industries adopt cloud MES more quickly. In February 2021, Atachi Systems promised the first fifty small pharmaceutical, medical device, and diagnostics firms that they would provide free MES software for one year. To tackle against the Coronavirus, it is necessary to speed up the development and commercialization of antiviral drugs, diagnostic instruments, and medical technology.

The worldwide industry may be hampered by the requirement of considerable capital expenditures for the deployment, upgrade, and maintenance of MES. The market expansion will be slowed down as a result of the willingness of smaller healthcare firms to secure appropriate funding for technological upgrades toward automation.

Market Segmentation

The Manufacturing Execution System (MES) Providers in Healthcare market is segmented into deployments and end-user. The deployment segment comprises Cloud Solutions, Corporate Datacenter Solutions, Hybrid Solutions, and On-Premise Solutions. The end-user segment includes Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies, and Other End-users.

According to regional analysis, Europe will lead the global Manufacturing Execution System (MES) Providers in Healthcare market during the forecast period due to rapid technical breakthroughs and system upgrades based on automation and manufacturing industry improvements.

Competitive Landscape

Some major key players in the Manufacturing Execution System (MES) Providers in Healthcare Market:

  • Andea,
  • Critical Manufacturing,
  • Dassault Systèmes,
  • GE Digital, Infor,
  • Körber,
  • LZ Lifescience Inc.,
  • Rockwell Automation,
  • Honeywell,
  • Trunovate,
  • NoMuda,
  • HCL Technologies Limited,
  • ORDINAL Software,
  • Atachi Systems,
  • ATS Global,
  • MasterControl, Inc.,
  • NNIT,
  • Aspen Technology Inc,
  • Goodly-Innovations GmbH,
  • ADVANCO SA,
  • Enhanced Information Solution,
  • POMS Corporation,
  • Tulip,
  • Siemens,
  • GFOS,
  • znt-Richter

Manufacturing Execution System (MES) Providers in Healthcare Market Report Scope

Report Attribute Specifications
Market Size Value In 2024 USD 4.0 Billion
Revenue Forecast In 2034 USD 17.4 Billion
Growth Rate CAGR CAGR of 15.9% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Mn, and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered Deployment, End-User
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber, LZ Lifescience Inc., Rockwell Automation, Honeywell, Trunovate, NoMuda, HCL Technologies Limited, ORDINAL Software, Atachi Systems, ATS Global, MasterControl, Inc., NNIT, Aspen Technology Inc, Goodly-Innovations GmbH, ADVANCO SA, Enhanced Information Solution, POMS Corporation, Tulip, Siemens, GFOS, znt-Richter, Other Prominent Players.Alkahest, Inc., Stealth BioTherapeutics, BIOPHYTIS BSA, SIWA Therapeutics, Rejuveron Life Sciences AG, Rubedo Life Sciences, Inc, Lineage Cell Therapeutics, Juvenescence Life, Longevity Biotech CohBar, Inc. (CWBR), Genome Protection Inc., Navitor Pharmaceuticals, Inc., Elevian, Inc., Other Prominent Players.
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Segmentation of Manufacturing Execution System (MES) Providers in Healthcare Market

Global Manufacturing Execution System (MES) Providers in Healthcare Market, by Deployment

  • Cloud Solutions
  • Corporate Datacenter Solutions
  • Hybrid Solutions
  • On Premise Solutions 

Global Manufacturing Execution System (MES) Providers in Healthcare Market, by End-User

  • Life science / Biotechnology Companies
  • Medical Device Providers
  • Pharmaceutical Companies
  • Other End Users 

Global Manufacturing Execution System (MES) Providers in Healthcare Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa 

North America Manufacturing Execution System (MES) Providers in Healthcare Market, by Country

  • U.S.
  • Canada

Europe Manufacturing Execution System (MES) Providers in Healthcare Market, by Country

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Manufacturing Execution System (MES) Providers in Healthcare Market, by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Manufacturing Execution System (MES) Providers in Healthcare Market, by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Manufacturing Execution System (MES) Providers in Healthcare Market, by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Enter Details and Get your PDF Brochure

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
9699
Security Code field cannot be blank!

Frequently Asked Questions

Manufacturing Execution System (MES) Providers in Healthcare Market Size is valued at USD 4.0 Bn in 2024 and is predicted to reach USD 17.4 Bn in 2034

Manufacturing Execution System (MES) Providers in Healthcare Market is expected to grow at a 15.9% CAGR during the forecast period for 2025-2034

Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber, LZ Lifescience Inc., Rockwell Automation, Honeywell, Trunovate, NoMuda

Deployment and End-User are the key segments of the Manufacturing Execution System (MES) Providers in Healthcare Market.

Europe region is leading the Manufacturing Execution System (MES) Providers in Healthcare Market.
Send Me the Sample Report Enquiry Before Buying